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ABSTRACT OF THE DISSERTATION 
 
A Multiplexed Approach to Defining Sequence-Function Relationships in Gene Expression 
using a Model Human Transcription Factor Binding Site 
 
by 
 
Jessica Elizabeth Davis 
Doctor of Philosophy in Biochemistry, Molecular and Structural Biology 
University of California, Los Angeles, 2019 
Professor Sriram Kosuri, Chair 
 
In this dissertation I present a complete characterization of the transcriptional activity of a 
model human transcription factor binding site (TFBS), the c-AMP Response Element (CRE), 
across varied cis-regulatory element architectures. The arrangement and assortment of TFBSs 
within cis-regulatory elements drive specific gene regulatory responses, yet it remains difficult to 
predict gene expression based on sequence alone. Part of this issue lies in our incomplete picture 
of how a single TFBS drives expression across various regulatory architectures differing in 
TFBS composition, TFBS affinity, TFBS number, distance between TFBSs, distance of TFBSs 
to transcription start sites, and sequence content surrounding TFBSs. To better our understanding 
on sequence-function relationships in eukaryotic gene expression, we designed and assayed 
9,126 synthetic regulatory elements isolating such TFBS variables. We developed and employed 
massively-parallel reporter assays (MPRAs) to enable episomal and genomic interrogation of 
 iii 
synthetic regulatory element activities in a human cell line. Overall, we find CRE number and 
affinity within regulatory elements largely determines expression, and this relationship is shaped 
by CRE proximities to promoter elements. Expression is not only dependent upon CRE’s overall 
distance to a downstream promoter, but also on its precise positioning and follows a ~10 bp 
periodicity along regulatory elements. Additionally, in the episomal MPRA, we find the spacing 
between multiple CREs dictates the phasing of expression periodicity in addition to overall 
expression. Lastly, we indicate differences between a single-copy genomic and episomal assay, 
highlighting the varied role certain TFBS variables have across regulatory contexts.  
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CHAPTER ONE 
 
Introduction 
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Gene regulation 
 Genes encode for molecules that define a cell and, on a larger scale, an organism. Yet it is 
the precise control over this process that enables biological complexity and survival. This 
regulation allows a cell to grow, reproduce, respond to environmental changes, and even 
differentiate into performing specific functions within an organism. The central dogma defines 
the backbone of this process, with DNA encoding for RNA (transcription) and RNA in turn 
encoding for proteins (translation), with many control and modification checkpoints scattered 
throughout these steps. RNA polymerase transcribes genes into RNA at one of the earliest points 
of control in this process. In eukaryotes, RNA polymerase II and its associated general 
transcription factors (TFs) bind elements in the genome, termed promoters, where this regulatory 
complex initiates transcription (Kornberg, 2007). Transcription factors, including the general 
factors of the pre-initiation complex, control the frequency of RNA polymerase II recruitment 
through interactions with other TFs, coregulators, the mediator complex, as well as to RNA 
polymerase itself (Bryant and Ptashne, 2003; Kornberg, 2007; Krumm et al., 1995; Lambert et 
al., 2018) in addition to modulating local nucleosome occupancy by recruiting chromatin-
modifying cofactors (Lambert et al., 2018; Spitz and Furlong, 2012). Cis-regulatory elements of 
the genome, such as promoters and enhancers, contain binding motifs for specific TFs, 
orchestrating the number, type, and arrangement of these interactions (ENCODE Project 
Consortium, 2012; Lambert et al., 2018). Thus, it is this assortment and placement of TF-binding 
sites (TFBS) that ultimately establishes interaction networks driving the first step in RNA 
polymerase II-directed transcription. 
 
Transcription factors drive transcription from cis-regulatory elements 
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There have been many efforts to characterize how combinations of TFBSs recruit 
transcription factors, and in turn, RNA Polymerase II. At a basic level, TF affinity for a sequence 
determines the duration of TF localization to a region of the genome. In vitro binding assays 
across thousands of synthetic sequences can determine TF position weight matrices (PWM), or 
the preference of a TF for each base in a binding site (Slattery et al., 2011; Tuerk and Gold, 
1990). Additionally, in vitro binding experiments have shown sequences flanking binding sites 
also influence TF-binding affinity (Levo et al., 2015). However, the orientation and spacing 
between these experimentally-derived motifs can further influence TF affinity for sequences with 
various motif combinations (Jolma et al., 2013, 2015). While this complicates predicting TF 
binding even in controlled environments, this may explain the large differences observed 
between the number of predicted TF-binding sites in the genome and how many regions are 
actually bound via ChIP-seq experiments (Wasserman and Sandelin, 2004). In addition, TFs 
indicating preferential binding based off of the GC content surrounding their site (Dror et al., 
2015) may also explain this phenomenon. Indeed, the likelihood of transcription factors to co-
bind correlates with their GC content preference, with regulators that prefer similar content co-
binding more frequently (Dror et al., 2015). Yet, TF-binding preferences determined from ChIP-
seq alone can be confounded by indirect binding events (Worsley Hunt et al., 2014), biases to 
open chromatin (Spitz and Furlong, 2012), and suffers from the lack of the sequence diversity 
that can be explored in binding assays that allow precise control over sequence composition. 
Furthermore, while these methods identify preferential motifs and TF-bound regions, these 
experiments do not determine the transcriptional impact of these sequences when bound.  
 TF recruitment to a cis-regulatory element has variable effects on transcription due to a 
number of factors. The exact placement of TFBSs can be highly conserved in close proximity to 
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core transcriptional machinery, such as surrounding transcription start sites (TSSs) of genes 
(Tabach et al., 2007), and such placement can be critical for transcriptional activity (Kim and 
Maniatis, 1997; Kim et al., 1998). TFBS not only organize TFs, but they dictate the phasing of 
these sites along the DNA helix and determine where short-range interactions with RNA 
Polymerase can occur, following ~10 bp intervals of activity (Kim et al., 2013). In addition to 
small changes in TFBS placement, the activities of certain TF indicate a dependence on overall 
TFBS proximity to the promoter/TSS (Tabach et al., 2007; Tinti et al., 1997). Lastly, some TFs 
require specific binding partners, such as other TFs and coactivators, to drive or inhibit 
transcription from a cis-regulatory element (Stampfel et al., 2015). Coupled with the lack of 
sequence diversity in cis-regulatory elements, this complicates the challenge of understanding 
how the precise composition of TFBSs within these regions results in gene expression. In order 
to piece apart the influence of these variables on transcription, many approaches have focused on 
a small set of changes performed to natural regions of the genome. Yet these studies are limited 
and confounded by the tested diversity of TFBS compositions, TFBS affinities, TFBS 
arrangements, distance of TFBSs to the TSS, and the sequence content surrounding TFBSs. 
Thus, we still lack a complete understanding of how the exact sequence composition of cis-
regulatory elements, and combination of TFBSs wherein, results in specific quantitative gene 
regulatory responses. 
 
Multiplexed approaches to characterizing TFBS logic 
 Thousands of synthetic regulatory elements designed and tested in vivo can isolate the 
effects of various cis-regulatory architectures on TFBS activity. Oligonucleotide microarray 
synthesis enables the multiplexed construction of large libraries (Fodor et al., 1991; Kosuri and 
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Church, 2014) to target such regulatory variables. By ensuring some way to track the activity of 
each sequence in a cell, one-pot experiments can then be performed, characterizing the 
transcriptional activity of library members in a single assay. Massively-parallel reporter assays 
(MPRAs) have emerged as one such method that utilize the scale of synthetic DNA libraries and 
next-generation sequencing to determine the expression of thousands of individual regulatory 
elements in pooled expression measurements (White, 2015). In many of these assays, library 
members are placed upstream of a cellular reporter and a unique transcribed region, called a 
barcode. These barcodes are either co-synthesized with library members or introduced following 
synthesis and associated to regulatory elements using next-generation sequencing (Urtecho et al., 
2019). This reporter plasmid pool is then transfected or integrated into a cell line or organism 
and DNA and mRNA is collected. Next-generation sequencing is then used to identify barcode 
abundance in each sample, which in turn determines relative expression levels of barcodes in the 
pooled assay, and thus the level of activity of the library members associated with those 
barcodes. Thus MPRAs enable a high-throughput and multiplexed analysis of cis-regulatory 
architecture, expanding existing biological sequence space and isolating the effects of potentially 
confounding variables within cis-regulatory elements. 
 MPRAs have started to isolate the regulatory effects of features shaping eukaryotic cis-
regulatory architecture. Many have used synthetic regulatory elements to determine the 
transcriptional effects of TFBS location (Sharon et al., 2012), sequences flanking TFBSs 
(Kwasnieski et al., 2012; Melnikov et al., 2012), active TF levels (van Dijk et al., 2017), 
homotypic site number (van Dijk et al., 2017; Gertz et al., 2009; Levo et al., 2017; Sharon et al., 
2012; Smith et al., 2013; Weingarten-Gabbay et al., 2019; White et al., 2016), site strength (van 
Dijk et al., 2017; Gertz et al., 2009; Kheradpour et al., 2013; Sharon et al., 2012), and heterotypic 
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TFBS combinations (Fiore and Cohen, 2016; Grossman et al., 2017; Levo et al., 2017; Smith et 
al., 2013; White et al., 2016). Typically such approaches use combinations of different TFBSs 
derived from natural regions of the genome or sometimes arranged between synthetic sequences. 
Many of these approaches have confirmed the findings of older, small-scale manipulations but at 
a higher-resolution enabled by the increase in sequences tested. From these a general picture 
emerges that combinations of different TFBSs generally illicit a greater response than 
combinations of the same TFBS, although no formal combinatorial logic has been presented 
across TFBSs (Fiore and Cohen, 2016; Grossman et al., 2017; Levo et al., 2017; Smith et al., 
2013; White et al., 2016). Site number in general follows a non-linear increase and saturation of 
expression, presumably due to saturated recruitment of RNA Polymerase II (Gertz et al., 2009; 
Sharon et al., 2012; Weingarten-Gabbay et al., 2019) although this response is shaped by active 
TF abundance in the cells tested (van Dijk et al., 2017). Additionally, one TFBS tested indicated 
a relationship between overall promoter proximity and transcriptional activity and in another 
case a ~10 bp periodicity in expression from changes in local TFBS placement (Sharon et al., 
2012). Many of these approaches have balanced the number of TFBSs assayed with the number 
of various architectures studied. As such, we still lack a complete characterization of the many 
variables acting upon a single TFBS in driving transcription and how these variables may 
interact in combination in cis-regulatory elements. 
 MPRAs are employed to approximate regulatory features and trends expected to act upon 
natural regions in the genome. Yet, in order to easily test the cellular activity of thousands of 
sequences, many MPRAs are performed episomally in which 101-104 copies of library members 
are present per nucleus (Cohen et al., 2009). This eases the burden of the cell numbers required 
to cover library complexity and collected RNA and/or DNA amounts needed for next-generation 
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sequencing. Yet, library members are assayed in an episomal rather than chromosomal context 
and are also in the presence of many other library members, potentially introducing binding 
competition for limited pools of available TF (Brewster et al., 2014; Lee and Maheshri, 2012). 
As an alternative to this format, some MPRAs have employed lentiviral library integration to 
reduce cellular copy numbers in addition to testing sequences in a genomic context (Inoue et al., 
2017; Klein et al., 2019). Yet, lentiviral vectors integrate randomly into the genome such that 
each library member is assayed in a different genomic context. Additionally, template switching 
prior to lentiviral-based integration results in inaccurate barcode-library member associations 
(Hill et al., 2018; Sack et al., 2016), further confounding results and placing constraints on 
library designs to avoid this issue (Klein et al., 2019). MPRAs integrating library members into a 
single, specific locus of the genome per cell avoid the pitfalls of lentiviral assays in addition to 
assaying sequences in a constant genomic context. A recent MPRA used CRISPR/Cas9 and 
homology-directed repair to integrate library members into the genome of a human cell line and 
observed robust results (Weingarten-Gabbay et al., 2019). Although such experiments are 
presumed to approximate chromosomal activity of library members, such assays drastically 
extend the amount of time to perform MPRAs, require greater experimental planning, and 
require handling of more cells in addition to processing greater amounts of biological material 
for next-generation sequencing. As of yet, no work has compared the impact of MPRA assay 
format on sequence-function relationships surrounding TFBS architecture within cis-regulatory 
elements. Therefore, it is still not apparent if these more intensive approaches in a genomic 
context are necessary for approximating more natural genomic trends. 
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A high-resolution analysis of c-AMP response element logic using a massively-parallel 
reporter assay 
 Here we simplify approaches to understand TFBS logic within cis-regulatory elements by 
focusing on a single model human TFBS, the c-AMP Response Element (CRE). The CRE 
Binding (CREB) protein binds CRE and drives expression downstream of adenylyl cyclase 
activation (Gonzalez and Montminy, 1989; Montminy et al., 1986) across most cell types (Mayr 
and Montminy, 2001). CRE is ideally suited for exploring associations between TFBS 
architecture and regulation due to its ability to drive expression without other TFBSs in 
regulatory elements (Melnikov et al., 2012) and its ease of inducibility in a cell (Gonzalez and 
Montminy, 1989; Montminy et al., 1986), allowing finer control over active concentrations of 
the CREB protein. The most conserved, and likely to be functional, CREs generally localize 
within 200 basepairs (bp) of a TSS in the human genome (Mayr and Montminy, 2001; Zhang et 
al., 2005). Additionally, a previous MPRA that performed scanning mutagenesis on a 
commercial CRE reporter found mutations to CREs in closer proximity to the promoter had a 
greater effect on expression in addition to mutations to sequences flanking CREs (Melnikov et 
al., 2012). Here we explore the relationship between CRE’s distance to promoter elements and 
its activity in greater detail, placing CRE in 1 bp intervals away from a promoter. We further 
explore the role other regulatory features play in modulating CREB protein activity including: 
CRE affinity, number, the spacing between multiple CREs, and the surrounding sequence 
content. Finally, we test our library both transiently and in a newly developed, singly-integrated 
genomic MPRA to better understand the quantitative and sometimes subtle differences between 
genomic and episomal assay context.  
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Abstract 
In eukaryotes, transcription factors orchestrate gene expression by binding to TF-Binding 
Sites (TFBSs) and localizing transcriptional co-regulators and RNA Polymerase II to cis-
regulatory elements. The strength and regulation of transcription can be modulated by a variety 
of factors including TFBS composition, TFBS affinity and number, distance between TFBSs, 
distance of TFBSs to transcription start sites, and epigenetic modifications. We still lack a basic 
comprehension of how such variables shaping cis-regulatory architecture culminate in 
quantitative transcriptional responses. Here we explored how such factors determine the 
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transcriptional activity of a model transcription factor, the c-AMP Response Element (CRE) 
binding protein. We measured expression driven by 9,126 synthetic regulatory elements in a 
massively parallel reporter assay (MPRA) exploring the impact of CRE number, affinity, 
distance to the promoter, and spacing between multiple CREs. We found the number and affinity 
of CREs within regulatory elements largely determines overall expression, and this relationship 
is shaped by the proximity of each CRE to the downstream promoter. In addition, while we 
observed expression periodicity as the CRE distance to the promoter varied, the spacing between 
multiple CREs altered this periodicity. Finally, we compare library expression between an 
episomal MPRA and a new, genomically-integrated MPRA in which a single synthetic 
regulatory element is present per cell at a defined locus. We observe that these largely 
recapitulate each other although weaker, non-canonical CREs exhibited greater activity in the 
genomic context. 
 
Introduction 
The ability for organisms to precisely control gene expression levels and responses is 
crucial for almost all biological processes. Expression levels are controlled by cis-regulatory 
elements such as promoters and enhancers, trans-acting factors such as transcription factors 
(TFs), and cell, epigenetic and environmental states. Cis-regulatory elements help direct 
transcription responses by localizing and orchestrating interactions between active transcription 
factors, co-regulators, and RNA Polymerase II (ENCODE Project Consortium, 2012; Lambert et 
al., 2018). For control of human gene expression, a variety of large-scale projects seek to 
determine gene expression levels across various cell lines and cell types (Lizio et al., 2015, 
2017), identifying functional elements that might control expression (ENCODE Project 
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Consortium, 2012), the genome-wide characterization of epigenetic states of DNA (Roadmap 
Epigenomics Consortium et al., 2015), and the binding specificities of transcription factors 
(Jolma et al., 2013, 2015; Yin et al., 2017; Zhu et al., 2018). Collectively, while these efforts 
generally give us a parts list of putatively functional elements, understanding how these parts 
define quantitative levels of expression is still not well understood. 
The combination of sequence motifs that recruit TFs, or TF-binding sites (TFBS), 
functionalize cis-regulatory elements via unique arrangements that help determine quantitative 
regulatory responses (Lambert et al., 2018; Spitz and Furlong, 2012). The consequences of subtle 
changes to TFBS compositions can be drastic. For example, clusters of weak-affinity Gal4 sites 
in yeast promoters increases expression synergistically, while stronger-affinity sites contributing 
to expression additively (Giniger and Ptashne, 1988). There can also be differences in TF 
occupancy of similar sequences in the genome that follow differences in the GC content of the 
surrounding sequence (Dror et al., 2015). Additionally, the placement of TFBSs can be highly 
conserved in close proximity to core transcriptional machinery, such as surrounding transcription 
start sites (TSSs) of genes (Tabach et al., 2007), and such placement can be critical for 
transcriptional activity (Kim and Maniatis, 1997; Kim et al., 1998). Lastly, the positional 
arrangement of TFBS combinations within cis-regulatory elements can modulate TF binding 
strength (Jolma et al., 2013, 2015) and TF activity can vary across the composition of TFBS 
combinations (Stampfel et al., 2015). Deciphering the logic imbued in cis-regulatory elements is 
difficult, as the limited set of natural variants and cell types are typically insufficient to control 
for variables such as sequence composition, TFBS composition and arrangements, and activity of 
trans-acting factors. Proving that particular sequences have causative effects on gene expression 
requires carefully controlled and high-throughput reverse-genetic studies. 
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The emergence of the massively parallel reporter assay (MPRA) allows for the testing of 
such reverse genetic transcriptional assays, and has become a powerful tool for the large-scale 
functional validation of regulatory elements across genomic and organismal contexts (White, 
2015). These assays utilize the scale of synthetic DNA libraries and next-gen sequencing to 
determine the expression of thousands of individual regulatory elements in pooled expression 
measurements, enabling high-throughput functional characterizations of cis-regulatory logic. 
MPRAs have been used to quantify the transcriptional strengths of cis-regulatory elements and 
identify the motifs integral to element activity (Ernst et al., 2016; Kheradpour et al., 2013). 
Furthermore, several groups are using these systems to dissect how individual TFBSs drive 
quantitative regulatory responses in bacteria (Belliveau et al., 2018), yeast (van Dijk et al., 2017; 
Gertz et al., 2009; Levo et al., 2017; Sharon et al., 2012), human cell lines (Fiore and Cohen, 
2016; Grossman et al., 2017; Weingarten-Gabbay et al., 2019), and animals (Kwasnieski et al., 
2012; Smith et al., 2013; White et al., 2016). Collectively, these studies have begun to dissect 
TFBS logic by exploring how the regulatory grammar of different site combinations, numbers, 
and placements affect transcriptional activity. 
Here we focus on how a range of factors guiding cis-regulatory architecture shape the 
activity of a single TFBS, the c-AMP Response Element (CRE). The CRE Binding (CREB) 
protein binds CRE and drives expression downstream of adenylyl cyclase activation (Gonzalez 
and Montminy, 1989; Montminy et al., 1986) across most cell types (Mayr and Montminy, 
2001). CRE is ideally suited for exploring associations between TFBS architecture and 
regulation due to its ability to drive expression without other TFBSs in regulatory elements 
(Melnikov et al., 2012) and its ease of inducibility in a cell (Gonzalez and Montminy, 1989; 
Montminy et al., 1986), allowing finer control over active concentrations of the CREB protein. 
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The most conserved, and likely to be functional, CREs generally localize within 200 basepairs 
(bp) of a TSS in the human genome (Mayr and Montminy, 2001; Zhang et al., 2005). 
Additionally, a previous MPRA that performed scanning mutagenesis on a commercial CRE 
reporter found mutations to CREs in closer proximity to the promoter had a greater effect on 
expression in addition to mutations to sequences flanking CREs (Melnikov et al., 2012). Here we 
explore the relationship between CRE’s distance to promoter elements and its activity in greater 
detail. We further explore the role other regulatory features play in modulating CREB protein 
activity including: CRE affinity, number, the spacing between multiple CREs, and the 
surrounding sequence content. Finally, although many MPRAs are performed episomally due to 
their ease and quickness (Fiore and Cohen, 2016; Grossman et al., 2017; Kheradpour et al., 2013; 
Melnikov et al., 2012), it’s been observed that episomal cis-regulatory element expression does 
not always correlate with their genomic counterparts (Inoue et al., 2017; Klein et al., 2019). 
Thus, we test our library both transiently and in a newly developed, singly-integrated genomic 
MPRA to better understand the quantitative and sometimes subtle differences between genomic 
and episomal assay context.  
 
Results 
CRE MPRA design and assay 
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We designed 
libraries with one or more 
CRE(s) by replacing 
sequence within three 
putatively inactive 150 bp 
background sequences to 
assay a range of features 
contributing to TFBS 
architecture (Figure 2.1 A). 
These backgrounds were 
adapted from sequences 
with little reported activity 
from the Vista Enhancer 
Database (Visel et al., 
2007) or a commercial 
reporter modified by 
removing previously 
identified CREs (Fan and 
Wood, 2007). We 
generated regulatory variants by replacing 12 bp regions of the backgrounds with either the 
consensus CRE (AT TGACGTCA GC), in which the central 8 bp region binds a CREB dimer 
(two monomer binding sites), or a weaker CRE (AT TGAAGTCA GC), where one of the central 
dinucleotides bound by both monomers was mutated and has been previously shown to reduce 
Figure 2.1 CRE regulatory library design, synthesis, and assays. (A) We replaced 
sequence within three putatively inactive backgrounds with consensus and/or mutant 
CREs to generate two libraries with varying spacing and distance to the minimal 
promoter (CRE Spacing and Distance Library) or the number and strength of the 
binding (CRE Number and Affinity Library). (B) We assembled the library reporter 
vectors with variants upstream of a minimal promoter, luciferase ORF, and a unique 
barcode sequence. The pool of library reporter vectors was assayed in a HEK293T cell 
line either by transient transfection or integrated at one allele of the Human H11 locus. 
(C) We stimulated CREB protein activity with forskolin, which activates cAMP 
signaling. Expression levels were determined as the ratio of barcodes reads in the 
RNA to that of the DNA sample. (D) Library expression following increasing 
forskolin concentrations in the episomal MPRA. Each variant is normalized to the 
expression of their corresponding background (no CREs), then averaged across 
replicates. (E) Variant expression exhibits strong correlation between biological 
replicates in both MPRAs, here shown at maximally-inducing concentrations of 
forskolin in both assays (episomal r = 0.99 and genomic r = 0.91).  
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activity (Mayr and Montminy, 2001; Melnikov et al., 2012). For the majority of analysis, we 
used two CRE libraries. The first library, the CRE Spacing and Distance Library, assays CREB 
activity as a function of both the spacing between CREs and CRE distance to the minimal 
promoter by moving two consensus CREs across the 150 bp backgrounds at six defined spacings 
(0, 5, 10, 15, 20 and 70 bp) between the two sites. In the CRE Number and Affinity Library, we 
explore the effect of both CRE number and affinity upon expression by designating 6 equally-
spaced locations across all backgrounds in which each location is replaced with either the weak 
CRE, consensus CRE, or no CRE.  
We used Agilent OLS synthesis to construct our designed libraries, added random 20 nt 
barcodes to the 3’ end, and mapped these barcode-variant associations. For MPRA analysis we 
only considered barcodes corresponding to perfect matches to our designs, identified at this stage 
via next-gen sequencing. We cloned these libraries into a reporter construct we engineered to 
maximize signal to noise when integrated into the genome (Figure 2.6 C) and then cloned a 
minimal promoter and luciferase gene between variant and barcode, placing the barcode in the 3’ 
UTR of the luciferase gene. The assays were conducted at varying induction conditions, either 
episomally by transient transfection (Episomal MPRA), or singly-integrated into the intergenic 
H11 safe-harbor locus (Zhu et al., 2014) using BxBI-mediated recombination (Genomic MPRA) 
(Duportet et al., 2014; Jones et al., 2019; Matreyek et al., 2017; Xu et al., 2013) (Figure 2.1 B). 
The episomal MPRAs were run in biological duplicate across 14 different concentrations of 
forskolin (Figure 2.1 D, Figure 2.6 E, and Figure 2.7), which stimulates phosphorylation and 
activation of the CREB protein by activating adenylyl cyclase (Gonzalez and Montminy, 1989). 
The genomic MPRA was run in biological duplicate at full induction (Figure 2.6 D). After 
forskolin stimulations, we isolated barcoded transcripts from cells and used next-gen sequencing 
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to determine barcode prevalence per RNA samples and plasmid (episomal MPRA) or genomic 
(genomic MPRA) DNA samples. Since each variant was mapped to multiple barcodes, we first 
determined the expression of each barcode via the ratio of normalized reads in the RNA over the 
DNA sample. We then determined variant expression from the median expression of all barcodes 
mapped to each variant. Both episomal and genomic MPRAs indicated high reproducibility 
between separately stimulated replicates (Figure 2.1 E, episomal Pearson’s r  = 0.99, genomic r  
= 0.91, and Figure 2.6 E). In both assays, the difference between backgrounds alone and a 
positive CRE control adapted from a commercially-available reporter plasmid (Fan and Wood, 
2007) spanned the majority of expression variation amongst variants. 
 
The role of CRE spacing and distance on expression 
We explored the extent to which positioning of CRE within a regulatory element 
quantitatively affects its transcriptional activity. We initially assayed the relationship between 
CRE distance relative to a downstream promoter and variant expression using 1 consensus CRE 
in a separate library, but found it drove minimal expression in the episomal MPRA after CREB 
activation (Figure 2.8). We then examined the expression driven by the CRE Spacing and 
Distance Library. This library varied the relative positioning of two consensus CREs with respect 
to the minimal promoter (referred to as CRE distance), and altered the number of nucleotides 
between the two sites (referred to as CRE spacing) (Figure 2.2 A). We tested spacings of 0, 5, 
10, 15, 20 or 70 bp between the two CREs, and then tested distance by moving these sites with 
each of the spacings across the backgrounds one base at a time, spanning the 150 bp 
backgrounds. Activation occurs in a dose-dependent manner in the episomal MPRA and we 
observe a ~10 bp expression periodicity that is more apparent at higher concentrations of 
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forskolin. This 10 bp periodicity 
was consistent across CRE 
spacings and backgrounds, 
displayed similar patterns between 
the genomic and episomal assays, 
but differed between backgrounds 
(Figure 2.9). Such periodicity has 
been observed before for single 
TFBSs in a variety of model 
systems (Kim et al., 2013; Sharon 
et al., 2012; Takahashi et al., 
1986). In addition, we also 
observed a general decrease in 
expression as CRE distance 
increased. Across backgrounds, 
MPRA formats, and CRE 
spacings, the change in median 
expression between the CRE 
distance range of 67-96 bp and 
147-176 bp resulted in a median 1.5 to 2.2-fold decrease in expression, with larger effects 
observed in the genomic MPRA (Figure 2.2 B).  
In addition, across CRE spacing, we noticed different phasings of expression periodicity. 
This was most pronounced in variants with background 41 in the episomal MPRA (Figure 2.3 
Figure 2.2 CRE proximity to promoter elements is associated with 
higher expression. (A) The expression profiles for two CREs that are 
10 bp apart display a periodic signal as they are moved away from the 
minimal promoter for Background 55 (with forskolin concentration 
shown in color).  The lines are 3 bp moving averages of the points. (B) 
Expression profiles for variants with Background 55 and 10 bp CRE 
spacing at maximally-inducing concentrations for both episomal and 
transient MPRAs (top panel). Expression decreases (lower panel) as 
the distance of the CREs from the proximal promoters increases across 
the backgrounds, spacings, and MPRA formats (as measured by the 
median expression across distance ranges 67-96 bp and 147-176 bp).  
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A). In particular, 5 and 15 bp CRE spacings exhibited similar local expression maxima at CRE 
distances 78 and 88 bp, whereas 10 and 20 bp spacings had maxima at 83 and 92 bp. This ~5 bp 
shift was also observed in background 55, albeit at different distances (Figure 2.10); it is of note 
we did not observe as clear changes in periodicity phasing in a genomic context. In these 
instances, we indicate distance from the minimal promoter to the start of the first CRE, such that 
the proximal CRE is in the same position across all expression profiles. Thus, the only 
differences between variants that may be causing this periodicity shift is the altered placement of 
the distal CRE following CRE spacings. Using the CREB bZIP structure bound to CRE 
(Schumacher et al., 2000), we modeled 2 dimers bound to CREs with 5 and 10 bp spacings 
(discussed in Methods) by aligning protein-DNA density to DNA backbone (Figure 2.3 B). It is 
of note, this simplified model does not incorporate density from full-length CREB proteins or 
both proteins’ effects on local DNA bending. A 5 bp shift in distances driving expression 
maxima between 5 and 10 bp spacings corresponds to about half a helical turn of B-form DNA 
(10.4 bp/turn). Our model positions the proximal CREB dimer (1) on the opposite face of the 
DNA helix between 5 and 10 bp spacings when they are both at their expression maxima. On the  
other hand, the distal CREB dimer (2) would be similarly oriented between the 5 and 10 bp 
spacings, but at a full helical turn distance from one another on the DNA.  
 To explore this phenomenon further, we designed a follow-up CRE Spacing and Distance 
Library varying spacings from 1-13 bp to encompass a full helical turn of relative CREB 
orientations. According to these spacings and the 8 bp CRE length, we expect CREB proteins to 
be co-aligned along the helix at both 2-3 bp and 12-13 bp spacings and we expect CREB 
proteins to lie on opposite sides of the helix at 7-8 bp spacings. The same backgrounds were used 
as before and CREs were similarly placed along these backgrounds at 1 bp intervals conserving 
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indicated spacings (Figure 2.3 C). When plotting the episomal MPRA expression of variants 
Figure 2.3 CRE spacing modulates expression periodicity as CRE distance is varied. (A) Average 
background-normalized expression of variants with background 41 in the episomal MPRA plotted as a 
function of distance between the minimal promoter and proximal CRE. Solid lines correspond to the 3bp 
moving average estimate and dashed lines indicate local expression maxima determined from 5 and 10 bp 
CRE spacings. Overlays indicate the offset of expression periodicities between 5 and 10 bp spacings and 
alignment between both 5 and 15 and 10 and 20 bp spacings. (B) Using the published structure of a 
CREB::bZIP dimer bound to CRE (PDB: 1DH3), we modeled the expected positioning of CREB dimers 
bound to the CRE proximal (1) and distal (2) to the promoter for both the 5 and 10 bp CRE spacings at the 
distances at their respective local maxima in A. Modeling approximates the distal dimer (2) in similar 
orientations at the two local expression maxima between spacings, with the proximal dimer on opposite faces 
of the DNA. (C) An additional CRE Spacing and Distance library was synthesized with CREs placed at all 
locations along the backgrounds with constant 1-13 bp spacings. Average background-normalized expression 
of variants with background 41 in a similarly-performed episomal MPRA are plotted as a function of distance 
between the minimal promoter and distal CRE. Across spacings, the placement of the distal CRE determines 
expression periodicity. Coupled with CREB dimer modeling across CREs with spacings, expression is 
minimal when both CREB proteins lie on opposite sides of the helix at 7-8 bp spacings. 
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now based on the distance from the distal CRE (2) to the promoter, we noticed a conserved 
pattern of ~10 bp expression periodicity across spacings (Figure 2.11). This alignment of 
expression periodicities across spacings was also observed across the different backgrounds. In 
contrast to the pronounced patterns observed with 12-13 bp spacings, in which CREB proteins 
are modeled to bind on the same face of the helix, expression was dampened at 7-8 bp spacings 
along the backgrounds, where CREB proteins are modeled to lie on opposite faces of the helix. 
We also noticed diminished expression for the short 1 bp spacing, in which we reasoned there 
may be binding site competition between CREs. Thus, it seems that the placement of the distal 
CRE (2), and presumably the orientation of the distal CREB protein, drives expression 
periodicity in these regions, while the placement of the proximal CRE (1) determines the 
amplitude of this response. 
 
The role of CRE number and affinity upon expression 
While CRE distance and spacing in regulatory elements help shape CRE’s activity, the 
overall number and affinity of CREs likely plays a larger role in determining expression. The 
design of the CRE Number and Affinity Library assays these effects while taking into 
consideration the contribution of CRE position. Each variant in this library contained unique 
combinations of consensus and weaker-affinity CREs spanning an assortment of 6 positions 
along the backgrounds (Figure 2.1 A). A constant 17 bp CRE spacing was implemented in this 
library design in order to sample a range of predicted CREB protein orientations along the DNA 
across the 6 positions (Figure 2.12). Even so, the number of consensus CREs alone largely 
determined variant expression and this relationship followed a non-linear increase and eventual 
plateauing of expression in both MPRA formats (Figure 2.4 A and Figure 2.12).  
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We 
observed a similar 
increase with the 
number of weak 
CREs if at least 
one consensus 
CRE was also 
present within the 
variant, although 
this effect varied 
per background 
and between 
episomal and 
genomic MPRAs. 
While the number 
of consensus 
CREs largely 
determined variant 
expression, there 
was a large 
amount of 
expression 
variability per 
Figure 2.4 CRE number and affinity largely determines variant expression with 
variation explained by CRE position and background. (A) The expression of variants 
with background 55 according to their number of consensus (x-axis) and weak (colored 
subsets) CREs in the integrated and episomal MPRAs. The change in median expression 
between variants with 1 consensus CRE and those with 1 consensus and 5 weak CREs is 
indicated. (B) A simple linear model was fit to log-transformed expression using the 
identities of the background and TFBSs at each position as inputs. (C) This fit model 
correlates well with measured expression for episomal (R2 = 0.90) and genomic (R2 = 
0.86) MPRAs and deviates from measurements of variants with no consensus CREs (left 
panel). Analysis of variance indicates 90% episomal and 86% genomic variance in 
expression is explained by the model. CREs occupying the two closest positions to the 
promoter had the strongest effects. The weights of categorical variables show the relative 
effects of strong and weak CREs and the effect of each background relative to variants 
with no CREs and with background 41.  
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arrangement of similar numbers of consensus and weak CREs, perhaps due to combinations of 
CREB protein orientations. To explore how the different arrangements of CREs across the six 
positions shaped expression per CRE combination, we fit a log-linear model of expression to the 
independent contributions of CREs at each position (Figure 2.4 B). We allowed different weights 
to be fit per CRE affinity per position and also included an independent background term to 
account for expression differences between backgrounds.  
We found this independent, position-specific model explained a majority of expression 
(Figure 2.4 C, left panels) in both the episomal (r = 0.95) and genomic MPRAs (r = 0.93). 
Although the model was inaccurate at predicting activity from low-expressing variants, this was 
largely due to variants with weak CREs and no consensus CREs driving little variation in 
activity in our assay. Accordingly, we found that CREs closest to the promoter (66 and 91 bp 
upstream of the promoter) explained 42.6% of the variance in the episomal MPRA and 43.8% in 
the genomic MPRA (Figure 2.4 C). This is expected as both positions fell within the ~110 bp of 
higher expression observed with the CRE Spacing and Distance library. None of the weights fit 
to CRE positions followed a trend in predicted CREB protein orientations (Figure 2.12), thus 
CRE’s distance to promoter elements may mask the subtle effects of CREB protein orientation 
previously observed with 2 CREs. Background alone explained 12.1% of the variance 
episomally and 18.4% of genomic expression variance. Overall, while we find that the number of 
consensus CREs per variant largely determined expression, the combination of CRE positions 
along the backgrounds and the backgrounds themselves explained a majority of expression in our 
assays. 
 
Differences between episomal and genomic MPRAs 
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There were a number of differences 
between the genomic and episomal 
expression trends resulting from increasing 
CRE numbers per variant. First, variants 
with weak CREs drove greater expression in 
the genomic MPRA, especially within the 
context of few consensus CREs per variant. 
For example, the change in median 
expression between variants with one 
consensus CRE and those with one 
consensus CRE and five weak CREs within 
background 55 was 1.4-fold in the episomal 
MPRA and 4.3-fold in the genomic MPRA 
(Figure 2.4 A). Second, expression plateaued 
at about six consensus CREs for most 
backgrounds and across forskolin 
concentrations in the episomal MPRA 
(Figure 2.13), while in the genomic MPRA, 
this occurred at about four consensus CREs 
for all backgrounds (Figure 2.4 A and Figure 
2.13). To explore differences in expression 
trends between the two MPRAs, we compared expression between the two assays according to 
different combinations of CRE affinities within variants (Figure 2.5 A). There was a strong linear 
Figure 2.5. Variants with weak CREs exhibit higher 
relative expression in a genomic context. (A) Variants 
across all backgrounds subset according to site affinity 
composition. Subsets include variants with 1-6 
consensus CREs (left panel), 1-6 weak CREs (middle) 
and combinations of 1-6 weak and consensus CREs 
(right). Variants with only consensus CREs drive similar 
relative expression (R2 = 0.92, red line) between 
genomic and episomal MPRAs. Most variants with 
weak CREs drive higher relative expression in the 
genomic MPRA compared to variants without weak 
CREs. (B) Variant expression according to their number 
of both consensus (x-axis) and weak CREs (colored 
subsets). Using the expression correlation line between 
variants with 1-6 consensus CREs in both MPRAs (red 
line) as a reference, the residual of each variant to this 
line is plotted along the y-axis. Variants containing 
higher numbers of weak CREs drive higher relative 
expression in the genomic MPRA while those with 
higher numbers of consensus CREs drive higher relative 
expression in the episomal MPRA. 
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relationship between genomic and episomal expression for variants containing one to six 
consensus CREs (Figure 2.5 A left panel, R2 = 0.92). Using this linear relationship as a reference 
(red line), we then compared expression between the two assays for variants containing one to 
six weak CREs (Figure 2.5 B middle panel) and combinations of one to six consensus and weak 
CREs (Figure 2.5 B right panel). Expression deviated from this linear relationship for variants 
containing weak CREs, with 79% of the variants exhibiting higher relative expression in the 
genomic MPRA. 
When we broke down this comparison according to numbers of consensus and weak 
CREs per variant, we observed higher relative genomic expression of weak CREs in the context 
of few (0-3) consensus CREs and higher relative episomal expression with combinations of at 
least 4 consensus CREs (Figure 2.5 B). This effect may be due to the differences in CRE variant 
copy numbers between assays. Lipofectamine transfections can result in 101-104 
plasmids/nucleus (Cohen et al., 2009). In this context, high numbers of variants with many 
consensus CREs may out-compete variants with weak CREs for CREB-protein binding. In 
similar systems, the titration of plasmids containing the same TFBS as a single chromosomal 
reporter has altered the expression of the chromosomal reporter (Lee and Maheshri, 2012) in a 
manner dependent upon the strength of the plasmid “competitor” sites and cellular TF 
concentrations (Brewster et al., 2014). Although multi-copy MPRAs are ideal for assaying large 
libraries of variants by reducing the number of cells required to cover library diversity, 
expression may be interpreted in the context of variant competition when variants contain similar 
TFBSs. Despite this, we show MPRAs that assay many variants per cell can largely recapitulate 
other TFBS features shaping genomic expression driven from single variants. 
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Discussion 
By performing synthetic manipulations of a single TFBS, the CRE, we present here a 
characterization of various regulatory rules governing TF activity. In particular, we assay the 
effects of CRE number, affinity, distance to promoter, and the spacing between multiple CREs 
within regulatory elements. Additionally, we show how a subset of these features shape 
expression when tested in combination. The limited complexity of natural cis-regulatory 
elements would not have allowed us to explore these features at bp-resolution and in such a 
controlled manner. Thus, we chose to isolate these features using synthesized regulatory 
elements in the format of an MPRA. Furthermore, we integrated variants at a single copy per cell 
within the same genomic environment to better approximate genomic expression. We present 
here improvements in a single-copy, defined-locus genomic MPRA performed in a human cell 
line, indicating the feasibility of reproducible expression measurements of lowly-expressing 
transcripts.  
 Although the variants assayed here are synthetic, we expect the regulatory trends 
observed to define expression from natural cis-regulatory elements as well. We observed a drop 
in transcription with placements of CRE beyond 120 bp distance to our minimal promoter, 
following similar findings with manipulation of native CREs (Tinti et al., 1997). Although it is of 
note that diminished expression periodicity was still observed at distances up to ~180 bp (Figure 
2.2 and Figure 2.9). CREB protein recruits RNA polymerase II through interactions with TFIID, 
while it’s phosphorylated form drives polymerase isomerization and transcription (Kim et al., 
2000). Thus CRE’s proximity to promoter elements may be integral to polymerase recruitment 
and transcription, perhaps explaining CRE’s enriched localization within 200 bp of TSSs in the 
human genome (Mayr and Montminy, 2001; Zhang et al., 2005). TF’s that also directly recruit 
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and activate RNA Pol II may also follow similar trends in activity according to TFBS promoter 
proximity. 
In addition to overall distance effects, CRE’s precise positioning likely plays a role in its 
activity in natural regulatory elements via the periodicity observed. In line with CRE’s 
localization around TSSs, conserved TFBSs that exhibit location-specificity in the genome are 
mostly found between 200 bp upstream and 100 bp downstream of a TSS (Tabach et al., 2007). 
For instance, manipulations that place the highly conserved 8 TFBSs in the IFN-ß enhanceosome 
at half a helical turn from the original 47 bp upstream of the TSS (Panne, 2008) reduce 
transcription (Kim and Maniatis, 1997; Thanos and Maniatis, 1995). These altered 
enhanceosome orientations hinder TF recruitment of TFIIB and coactivator CREB protein 
binding protein (CBP), which binds RNA Pol II (Kim et al., 1998). While CREB protein 
similarly drives transcription through interactions with CBP (Zhang et al., 2005), it is unclear 
how such interactions across 2 CREB proteins in local proximity would drive the observed 
expression periodicities. Additionally, it is surprising that the more distal CRE drove expression 
periodicity in variants with 2 CREs when CRE promoter proximity drives overall expression. 
Along with other bZip proteins, CREB protein indicates a positional binding preference around 
nucleosomes (Zhu et al., 2018) such that binding events are more often observed when their 
motifs are in certain orientations proximal to nucleosomes. While preferred orientations of the 
most distal CREB protein with respect to an upstream nucleosome may explain the expression 
periodicity observed here, further characterizations of TF-nucleosome interactions are necessary 
to prove this effect. This phenomenon is even more uncertain in an episomal context, where we 
observed large changes to periodicity phasing, due to altered histone ratios (Hebbar and Archer, 
2008) and placement of nucleosomes (Jeong and Stein, 1994) on transient plasmid DNA 
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constructs in comparison to their genomic counterparts. Since we did not observe such changes 
in the genomic context, further work is needed to resolve the differences TFBS positioning plays 
in driving expression between episomal and chromatin contexts. 
With combinations of TFBSs within a cis-regulatory element the effect of spacing 
between sites plays a role on both the recruitment of TFs, via TF-induced DNA bending and TF-
DNA interactions, in addition to aligning TF interactions with other regulatory partners. While 
CREB protein-induced DNA bending is minimal, estimated at 10° from its crystal structure 
(Schumacher et al., 2000), this nevertheless may play a role on CREB protein binding of two 
CREs in close proximity. Even minor protein-induced DNA bending indicates changes to major 
groove widths, and this change plays a role in TF-binding affinities, resulting in a similar ~10 bp 
periodicity in in vitro studies (Kim et al., 2013). Indeed, these experiments indicated a preference 
for protein binding on similar faces of the helix as opposed to opposite faces between proteins 
that similarly modify major groove width. Although it is difficult with our assay format to 
separate the effect of CRE spacing on TF-binding from TF transcriptional activity, such 
observations may explain the dampening in expression periodicity observed with 2 CREB 
proteins on opposite faces of the helix. 
The number of consensus CREs largely determined expression in our assays, following 
similar trends as other homotypic clusters of TFBSs assayed (van Dijk et al., 2017; Gertz et al., 
2009; Sharon et al., 2012; Weingarten-Gabbay et al., 2019). In contrast, a recently published 
MPRA in human cell lines found increasing number of CREB binding sites did not increase 
expression, although these sites were assayed in the absence of forskolin (Weingarten-Gabbay et 
al., 2019). Although the number of sites generally increase expression in both MPRAs tested 
here, there are instances in which variants drive less expression following increasing consensus 
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CRE number. In the genomic MPRA for example, many variants of a particular background 
drive higher expression with 4 consensus CREs than that of variants with 5 or 6 (Figure 2.4 A 
and Figure 2.13). In some of these examples, higher expression is observed with the addition of a 
weak CRE to a variant as opposed to a consensus CRE. Closely-spaced TFBSs can restrict the 
diffusion of TFs along DNA if one is already bound (Hammar et al., 2012), leading to binding 
competition between binding sites. This competition has been implicated in decreasing 
expression in a similar TFBS MPRA (van Dijk et al., 2017) and may explain our observations in 
the genomic MPRA. This effect is not as apparent in the episomal MPRA, a feature that may be 
explained by predominantly measuring competition between plasmids over competition between 
CREs in a single variant.   
Lastly, we provide further evidence MPRA design and regulatory context must be 
considered in characterizations of regulatory features shaping expression. In both MPRAs, the 
contribution of background to variant expression is more predictive of variant activity than the 
presence of CRE at many positions along these backgrounds. The surrounding sequence content 
may play a similarly significant role for many other TFBSs, especially those that exhibit a bias in 
binding events based on the GC content similarity of the surrounding sequence to that of the 
TFBS itself (Dror et al., 2015). Therefore, we recommend incorporating multiple sequences as 
backgrounds in similar synthetic regulatory element designs especially since the use of a single 
background, as has been employed in many MPRAs, can influence TFBS trends observed 
(Figure 2.13). Additionally, we indicate here the ability of episomal assays to approximate 
genomic regulatory rules, yet also warn of the potential pitfalls of transient assays. Overall, we 
observe strong correlation between our episomal and genomic MPRAs (Figure 2.14, Pearson’s r 
= 0.91). Yet the activity of variants with weaker-affinity CREs varies considerably between 
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assays, which may be explained by differences in variant, and hence CRE, copy numbers in a 
cell. Thus we would not expect this effect to skew expression measurements of libraries assaying 
a high diversity of TFBSs. Alternatively, this could also be attributed to more consistent genomic 
structure in chromatin. 
While we characterize various regulatory rules shaping the activity of a single TFBS, the 
CRE, we use this as a model to estimate a small fraction of the complexity of expression attained 
by combinations of TFBSs in natural cis-regulatory elements. Exploring how these rules scale 
with other TFBSs is integral to our understanding of cis-regulatory logic. Similar high-
throughput approaches can build from the constraints explored here to develop more complex 
dissections of TFBS architectures. Transcriptional activation is thought to occur via phase-
separated TF-coactivator-Pol II hubs, with local concentrations of these factors driving 
expression non-specifically (Boehning et al., 2018; Chong et al., 2018; Reiter et al., 2017). The 
interplay between transcriptional activity in these phase-separated systems and TFBS grammars 
needs further exploration. Further characterizations using similar synthetic systems will further 
our comprehension of cis-regulatory elements and our ability to confidently compose new ones 
with predictable activities.  
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Materials and Methods 
 
CRE regulatory library design 
The CRE regulatory library was designed using three 150 bp backgrounds as templates 
and either a consensus CRE, taken from the CREB1 sequence logo in the JASPAR database, or 
weaker-affinity CRE, in which one of the central dinucleotides important for binding of both 
CREB protein monomers was mutated (Mayr and Montminy, 2001; Melnikov et al., 2012). Two 
of the backgrounds were adapted from previous MPRAs (background 55 (Melnikov et al., 2012) 
and background 41 (Smith et al., 2013)) and a third was isolated from a human genomic region 
indicating minimal activity in the developing eye in the VISTA enhancer database (Visel et al., 
2007) (background 52). Both background 41 and 52 were obtained from the human genome, 
with 41 corresponding to Chr9: 81,097,684-81,097,833 and 52 to Chr5: 89,377,854-89,378,003 
from GRCh38. Background 55 corresponds to the CRE response element of a commercial 
reporter plasmid (Fan and Wood, 2007) with a portion duplicated to reach 150 nt and with all 
CREs scrambled, maintaining their GC content. Variants were generated by replacing 
background sequence with CREs along with a constant 2 bp flanking nucleotides to ameliorate 
local sequence effects due to CRE placement in the backgrounds (Levo et al., 2015). A MluI 
restriction enzyme site (ACGCGT) was placed upstream of each variant and KpnI restriction 
enzyme site (GGTACC) was placed downstream, each for library cloning. Lastly, a pair of 19 nt 
amplification primers (Eroshenko et al., 2012) specific to each of the 2 library designs were 
added to each design producing 200 nucleotide libraries of the format: (5’ -> 3’) subpool primer 
1 - MluI - variant - KpnI - subpool primer 2. The resulting 4185 variants corresponding to the 2 
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designs in Figure 2.1, 417 variants corresponding to the single-CRE library, and one CRE 
positive control (Fan and Wood, 2007) were all synthesized on Agilent Microarrays.  
 
Library cloning 
 OLS libraries (Agilent Technologies, Santa Clara, CA) were resuspended to a final 
volume of 200 nM in TE pH 8.0 (Sigma-Aldrich, Saint Louis, MO). Libraries were amplified 
using 1 µL of a 10-fold dilution of the library, the respective subpool primer pairs (Subpool_#_F 
and Subpool_#_R with # representing the sub-libraries present, 2 refers to the single CRE 
Distance library, 3 refers to the CRE Spacing and Distance library, and 5 refers to the CRE 
Number and Affinity library) and with KAPA HiFi HotStart Real-time PCR Master Mix (2X) 
(Kapa Biosystems, Wilmington, MA) following the recommended cycling protocol at 14 cycles. 
Random barcodes were added to variants in a second PCR in which the primer downstream of 
variants contained 20 nucleotides of random sequence, synthesized with the machine-mixed 
setting (Integrated DNA Technologies, Coralville, IA). One ng product was used in this 
barcoding qPCR using biotinylated primers (SP#_Biotin and SP#_Biotin_BC_R with subpool 
numbers corresponding to library designs as before). The qPCR was performed with KAPA HiFi 
HotStart Real-time PCR Master Mix (2X) (Kapa Biosystems) for 11 cycles following the 
recommended cycling protocol. Barcoded libraries were digested with MluI-HF (New England 
Biolabs, Ipswich, MA) and SpeI-HF (New England Biolabs) in 1X cut-smart buffer (New 
England Biolabs). The biotinylated primers and undigested library members were removed using 
Dynabeads M-270 Streptavidin (Thermo Fisher Scientific, Waltham, MA), using the 
recommended “Immobilize nucleic acids” protocol, collecting the supernatant after adding the 
library mixture to the beads.  
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The barcoded and digested library members were cloned into the integration vector 
(pJDrcEPP) that had previously been digested using MluI-HF and SpeI-HF in 1X cut-smart 
buffer (New England Biolabs). Ligation was performed at a 1:3 ratio of pJDrcEPP:library using 
T4 DNA ligase (New England Biolabs). Ligation product was cleaned-up using a Clean and 
Concentrator Kit (Zymo Research, Irvine, CA) followed by drop-dialysis for 15 minutes with 
UltraPure™ DNase/RNase-Free Distilled Water (Thermo Fisher Scientific) before transforming 
1 µL into NEB 5-alpha Electrocompetent E. coli (New England Biolabs) following the 
recommended protocol. Dilutions of transformants were plated on 50 µg/mL Kanamycin (VWR, 
Radnor, PA) LB plates at 10-fold dilutions to 1/10,000 and grown overnight at 37°C and the 
remainder of the cells were left in SOC (New England Biolabs) at 4°C overnight. The next day, 
dilutions were counted, estimating 695,000 and 950,000 original transformants for the placement 
and spacing library and the number and affinity library, respectively. The remainder 
transformants kept overnight at 4°C were pelleted and placed in fresh LB for 3 hours at 30°C, 
then diluted into 100x volume LB + 50 µg/mL Kanamycin (VWR) and grown at 30°C for 18 
hours before isolating library vectors using QIAprep (Qiagen, Hilden, Germany) spin miniprep 
kits. 
Library vectors (pJDrcEPP_lib) were then digested in 2 steps, in order to isolate plasmids 
correctly cut at the synthesized KpnI recognition site. Vectors were first digested with KpnI-HF 
along with rSAP (New England Biolabs) in 1X CutSmart buffer. Products were run on a 0.8% 
TAE agarose gel and linearized plasmids were isolated with Zymoclean Gel DNA Recovery Kit 
(Zymo Research). Vectors were then digested in a similar fashion with XbaI (New England 
Biolabs) without gel isolation. The minimal promoter and luciferase insert was prepared using 
biotinylated PCR primers (Amp_minPLuc2_Biotin_For and Amp_minPLuc2_Biotin_Rev) 
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corresponding to pMPRAdonor2 (Addgene plasmid #49353) and Kapa HiFi HotStart ReadyMix 
(Kapa Biosystems). The insert was digested with both KpnI-HF and XbaI (New England 
Biolabs). Biotinylated primers and undigested inserts were removed as before using Dynabeads 
M-270 Streptavidin (Thermo Fisher Scientific). Ligation of pJDrcEPP_lib and minP-Luc2 inserts 
was performed at a 1:3 ratio as before but with T7 DNA ligase (New England Biolabs). Ligation 
product was cleaned-up and transformed as before, plating similar dilutions but instead growing 
the remainder transformants overnight in 100x LB + Kanamycin (50 µg/mL) (VWR) at 30°C. 
The next day, dilutions were counted, estimating 15,877,000 and 17,845,000 original 
transformants for the placement and spacing library and the number and affinity library, 
respectively. Library vectors with insert (pJDrcEPP_lib_minPLuc2) were isolated from the 
remainder transformants using Qiagen Plasmid Plus Maxi Kit (Qiagen). 
 
Barcode mapping 
 Barcodes were associated with each library member by sequencing amplicons isolated 
from pJDrcEPP_lib. 0.5 ng of plasmid was amplified using primers with P5 and P7 Illumina 
flow cell adapter sequences (Libseq_P7_For and Libseq_P5_Rev) and KAPA HiFi HotStart 
Real-time PCR Master Mix (2X) (Kapa Biosystems) for 17 cycles. Amplicons were isolated on a 
2% TAE agarose gel and bands were confirmed using Agilent’s D1000 ScreenTape and reagents 
(Agilent Technologies) on a 2200 Tapestation system. Libraries were sequenced on an Illumina 
MiSeq with a v3 600-cycle reagent kit (Illumina, San Diego, CA) using custom read 1 primer 
LibSeq_R1Seq_Rev and custom read 2 primer LibSeq_R2Seq_For loaded into the cartridges 
read 1 and read 2 primer wells, respectively. 35,355,712 reads passed filter and 31,486,576 reads 
were merged with BBMerge version 9.00. A custom python script was used to map unique 
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barcodes to variants lacking synthesis errors. Briefly, this script searched the last 150 bp of 
merged reads for sequences perfectly matching the variants designed. The first 20 bp of each 
merged read was determined to be a barcode and each barcode was then mapped to the most 
common sequence associated with it, only retaining barcodes that appeared more than twice in 
merged reads. In order to differentiate between mapped barcodes that are associated with 
variants with sequencing errors and another variant in the library, we used a Levenshtein 
distance cut-off of 13 between variants that share a common barcode. This cut-off represented 
1% of the total bootstrapped distances between perfect variants in the library. Barcodes mapped 
to perfect variants were kept if all other variants associated with a barcode fell below this cut-off, 
retaining 724668 barcodes. 
 
Genomic MPRA Library integration 
 2.6 x 106 Hek293T H11 landing pad cells were plated per T75 flask, 6 flasks in total, and 
grown in DMEM with 1% Penicillin-streptomycin and 10% FBS (Thermo Fisher Scientific); this 
is the cell media used in all tissue culture work unless otherwise stated. The next day, the cells 
were transfected with a total of 187.5 µL Lipofectamine 3000 (Thermo Fisher Scientific), 6.252 
mL Opti-MEM (Thermo Fisher Scientific), 13.86 µg BxB1 expression vector (Duportet et al., 
2014), 153.36 µg spacing and distance library vector, 180 µg number and affinity library vector 
and 250 µL P3000 (Thermo Fisher Scientific) following the recommended protocol. BxB1 was 
added to the DNA mixture at a 1:8 ratio, while both libraries were added at 3x to increase 
efficiency. Cells were passaged after 3 days onto a T875, in which the media was changed to 1 
µg/mL puromycin (Life Technologies, Carlsbad, CA) selection media. Unless otherwise stated, 
cells were passaged in all tissue culture work according to: trypsinization with Trypsin-EDTA 
 45 
0.25% (Thermo Fisher Scientific) followed by inactivation with 2x volume of cell media, 
pelleting at 1000 x g for 5 minutes and resuspension in fresh media. 1/160 of the cells were 
removed before selection and grown without puromycin to analyze overall integration efficiency. 
The selection cells were passaged at 1:10, 1:20 or at 1:1 as needed during selection every 1-4 
days, with 6 passages in total over 16 days of selection. Cells plated for integration efficiency 
analysis were passaged at 1:10 or 1:20 every 3 or 4 days for a total of 6 passages. Both cells were 
analyzed using flow cytometry 20 days after transfection, shown in Figure 2.6 B. Samples were 
prepared in PBS pH 7.4 (Thermo Fisher Scientific) using the LSRII at the UCLA Eli & Edythe 
Broad Center of Regenerative Medicine & Stem Cell Research Flow Cytometry Core. Cytometer 
settings were adjusted to: FSC – 157 V, SSC – 233 V, Alexa Fluor 488 – 400 V. Selected cells 
were frozen at 5 x 106 cells/mL in 5% DMSO (Thermo Fisher Scientific) and aliquots were used 
in the genomic MPRA. 
 
Luminescence assays 
 For the landing pad orientation luminescence assay (Figure 2.6 C), 22 x 103 cells 
containing integrated control sequences were plated in triplicate across a 96-well plate. 100x 
forskolin stocks were made via serial dilution in DMSO (Thermo Fisher Scientific) , and 1x 
forskolin solutions were made in CD 293 media (Thermo Fisher Scientific) supplemented with 4 
mM L-Glutamine (Thermo Fisher Scientific). The next day, media was removed from all 96-
wells and replaced with 25 µL of media with forskolin (0, 0.5, 1, 5, 10, 50, 100, and 120 µM). 
After 4 hours, fluorescence was measured using the Dual-Glo Luciferase Assay Kit (Promega, 
Madison, WI), in which 10 µL of Dual-Glo Luciferase Reagent was added, cells were shook for 
10 minutes and luminescence was measured on a plate reader. 
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 For the MPRA library luminescence assays (Figure 2.6 D), 880,000 H11 landing pad 
cells and the genomic MPRA cells were resuspended in 12 mL media and 100 µL was 
distributed per well across a 96-well plate. The next day, the H11 landing pad cells were 
transfected with a total of 6.6 µL Lipofectamine 3000, 220 µL Opti-MEM , 0.44 µg Renilla 
luciferase expression vector, 2.15 µg spacing and distance library vector, 2.79 µg number and 
affinity library vector and 8.8 µL P3000 (Thermo Fisher Scientific) following the recommended 
protocol, using 10 µL of this mixture per 96-well. 100x forskolin stocks were made via serial 
dilution in DMSO (Thermo Fisher Scientific), and 1x forskolin solutions were made in cell 
media. Media was removed from all 96-wells and replaced with 25 µL of media with forskolin 
(0, 1, 2, 4, 8, 16, and 25 µM). After 4 hours, fluorescence was measured using the Dual-Glo 
Luciferase Assay Kit (Promega), in which 10 µL of Dual-Glo Luciferase Reagent was added, 
cells were shook for 10 minutes and luminescence was measured on a plate reader. Renilla 
luminescence from the transfected cells was measured following Stop & Glo Reagent addition. 
 
Episomal MPRA 
 Two mL of a 1.026 x 105 cells/mL stock of H11 Landing Pad cells were plated per 6-well 
per biological replicate. The next day, cells were transfected with a total of 64.5 µL 
Lipofectamine 3000, 4.3 mL Opti-MEM, 18.1 µg CRE Spacing and Distance library vector, 21.9 
µg CRE Number and Affinity library vector and 86 µL P3000 (Thermo Fisher Scientific) 
following the recommended protocol, using 250 µL of this mixture per 6-well. Both library 
vectors were concentrated using a Wizard SV Gel and PCR Clean-up (Thermo Fisher Scientific) 
prior to transfection. 100x forskolin stocks were made via serial dilution in DMSO (Thermo 
Fisher Scientific), and 2x forskolin solutions were made in cell media. The next day, 2 mL of 
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media with 2x forskolin was added to the 2 mL media within each 6-well (final concentrations: 
0, 2-5, 2-4, 2-3, 2-2, 2-1, 20 and 22 µM forskolin). After 3 hours, RNA was collected using Qiagen 
RNeasy Mini Kits with Qiashredder and on-column DNase I digestions with Qiagen RNase-free 
DNase Set (Qiagen).  
Per sample, RNA was reverse-transcribed using 1.5x the recommended materials for 
Superscript IV Reverse Transcriptase (Thermo Fisher Scientific) with 7.5 µg total RNA and the 
library-specific primer Creb_Hand_RT, which anneals downstream of barcoded transcripts. The 
recommended protocol was followed with changes including reverse transcription at 55°C for 1 
hour and RNase H (Thermo Fisher Scientific) removal of RNA in RNA:DNA hybrids. To ensure 
the same amount of barcoded cDNA was used per PCR across forskolin concentrations and that 
this amount covered library complexity, a preliminary qPCR of total RNA samples was 
performed alongside serial dilutions of a known amount of barcoded cDNA previously 
amplified. Sample Cq’s were referenced to Cq’s of the serial dilutions to determine approximate 
concentrations of barcoded transcripts per total RNA loaded. Volumes of samples that 
approximated 6000-fold coverage of the number of variants (not including barcode complexity) 
were determined and used in the following PCR.   
cDNA was amplified with NEBNext Q5 Hot Start HiFi PCR Master Mix (New England 
Biolabs) using input amounts determined from qPCR, distributed across 4 replicates each so as 
to not exceed 10% of the total PCR volume, and with primers specific to luciferase 
(Creb_Seq_Luc_R) and a 20 nt annealing site added during reverse-transcription (Creb_Hand). 
PCR conditions were followed as recommended with 61°C annealing for 20s, extension at 72°C 
for 20s and a final extension at 72°C for 2 minutes for a total of 10 cycles. Meanwhile, library 
plasmids mixed at the same ratio as for transfection were used for DNA normalization in the 
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episomal MPRA. 128 ng of this mixture was used per PCR with NEBNext Q5 Hot Start HiFi 
PCR Master Mix (New England Biolabs) along with the reverse-transcriptase primer 
(Creb_Hand_RT) and the primer specific to luciferase (Creb_Seq_Luc_R) using the same PCR 
conditions for cDNA for 9 cycles. Amplicons were isolated on a 2% TAE gel, after which they 
were cleaned-up again. 
A second PCR was performed on both the cDNA and plasmid DNA amplicons in order 
to add P5 and P7 Illumina flow cell adapter sequences and indices. NEBNext Q5 Hot Start HiFi 
PCR Master Mix (New England Biolabs) was used with 0.5 ng input and the primers 
P5_Seq_Luc_F and P7_Ind_#_Han or P7_In_####_Han, with # corresponding to the index code 
per sample indicated in Table 2.1. PCR conditions were followed as recommended with 63°C 
annealing for 20s, extension at 72°C for 25s and a final extension at 72°C for 2 minutes for a 
total of 7 cycles. Bands were confirmed using Agilent’s D1000 ScreenTape and reagents 
(Agilent Technologies) on a 2200 Tapestation system. Samples were mixed equally and 
sequenced on a NextSeq500 at the UCLA Technology Center for Genomics & Bioinformatics 
(TCGB) using the 1 x 75 v2 kit (Illumina) with only 30 cycles. Before sequencing, the custom 
read 1 sequencing primer Creb_R1_Seq_P and indexing primer Creb_Ind_Seq_P were loaded 
into the read 1 and index primer positions in the NextSeq cartridge. 365.67 x 106 reads passing 
filter were obtained across the 8 dilutions (2 replicates each) and plasmid DNA sample with 
reads per index ranging between 12 x 106 and 20 x 106. 
The episomal MPRA performed at concentrations beyond 1 µM forskolin indicated in 
Figure 2.7 was similarly transfected and prepped according to the above protocol but with 
incubations at 0, 20, 21, 22, 23, 24, 25, 25 and 26 µM forskolin. Samples were sequenced on the 
NextSeq500 using the 1 x 75 v2 kit (Illumina) with 75 cycles and 305.06 x 106 reads passing 
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filter were obtained across the 9 dilutions (2 replicates each) and plasmid DNA sample with 
reads per index ranging between 10 x 106 and 14 x 106. The single CRE library indicated in 
Figure 2.8 was similarly transfected and prepped according to the above protocol but with 
incubations at 0 and 25 µM forskolin. Additionally, volumes of cDNA samples that 
approximated 1500-fold coverage of the number of variants (not including barcode complexity) 
were determined and used in the following PCR. 101.55 x 106 HiSeq reads passing filter were 
obtained across all cDNA and plasmid DNA samples.  
 
Genomic MPRA 
2.5 x 105 Genomic MPRA library-integrated and selected cells were plated on 2 separate 
6-wells, forming the two biological replicates used in the Genomic MPRA. These cells were 
passaged twice in their expansion, after which cells were frozen at 5 x 106 cells/mL in 5% 
DMSO (Thermo Fisher Scientific). For the Genomic MPRA, 5 aliquots of each replicate, 2.5 x 
107 cells total, were thawed and grown to cover the initial bottleneck amount 100-fold. 2 days 
later these cells were trypsinized and plated for stimulation at 3.47 x 10^6 cells per 150 cm plate 
with 20 mL of media, eight plates total per replicate. Two days later, both replicates were 
stimulated by adding 20 mL of media with 16 µM forskolin to the 20 mL media already on 
plates. After 3 hours, replicates were trypsinized, combined, spun down at 1000 x g for 5 
minutes, resuspended in media and split evenly into 2 tubes, one RNA extraction and one for 
genomic DNA extraction.  
 Cells aliquoted for RNA processing were spun down and resuspended in 3.2 mL of RLT 
(1% ß-Mercaptoethanol) from a Qiagen RNeasy Midi kit (Qiagen). Cells were homogenized by 
passing the lysate through an 18-gauge needle 10 times and were stored at -80°C. Two days later, 
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lysates were thawed and processed according to the RNeasy Midi Protocol for Isolation of Total 
RNA from Animal Cells from Qiagen RNeasy Midi/Maxi Handbook (09/2010) (Qiagen) starting 
at the addition of 1x volume of 70% ethanol to thawed lysates. On-column DNase I digestions 
were performed with the Qiagen RNase-free DNase Set (Qiagen). RNA was eluted with 200 µL 
RNAse-free water (Qiagen) and subsequently concentrated using an Amicon Ultra-0.5 mL 
Centrifugal Filter with a 10 kDa cut-off. Total RNA was stored at -20°C. 
 Cells aliquoted for genomic DNA were spun down and resuspended in PBS pH 7.4 
(Thermo Fisher Scientific) twice to give a final concentration of 1 x 107 cells/mL. Samples were 
processed according to the Sample Preparation and Lysis Protocol for Cell Cultures from 
QIAGEN Genomic DNA Handbook (08/2001) using the settings for the Qiagen Blood and Cell 
Culture DNA Maxi Kit (Qiagen). Pelleted nuclei were frozen at -20°C before G2 buffer was 
added. Two days later, nuclei were thawed and the remainder of the protocol was followed using 
Qiagen Protease digestion at 50°C for 60 minutes, and precipitating DNA according to the 
recommended protocol for vortexing and centrifugation after isopropanol addition followed by 
washing with cold 70% ethanol. Genomic DNA was resuspended in 800 µL Qiagen Elution 
Buffer (Qiagen) and left at room temperature overnight. The next day, gDNA was shook at 600 
rpm for 3 hours at 55°C. RNase A (DNase and protease-free, Thermo Fisher Scientific) was 
added to a final concentration of 99 ng/µL. Over the next 3 days, 600 µL Qiagen Elution Buffer 
(Qiagen) was added incrementally, with additional shaking at 55-60°C after each addition for a 
total of 28 hours; this was largely due to resuspension issus. Resuspended DNA was stored at 
4°C. 
 Per replicate, 130 µg total RNA was reverse transcribed using the recommended 
materials for Superscript IV Reverse Transcriptase (Thermo Fisher Scientific) but with 10 µg 
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total RNA instead of the recommended 5 µg per 20 µL reaction. The library-specific primer 
Creb_RT_Hand_3, which anneals downstream of barcoded transcripts, was added to reactions 
and the recommended protocol was followed with changes including reverse transcription at 
55°C for 1 hour and RNase H (Thermo Fisher Scientific) removal of RNA in RNA:DNA 
hybrids. RNAse A (DNase and protease-free, Thermo Fisher Scientific) was added to each 
reaction at a final concentration of 100 ng/µL and incubated at 37°C for 30 minutes. Reactions 
were combined and concentrated using an Amicon Ultra-0.5 mL Centrifugal Filter with a 10 kDa 
cut-off (Sigma-Aldrich). To ensure the same amount of barcoded cDNA was used per PCR 
across replicates and that this amount covered library complexity, a preliminary qPCR of total 
RNA samples was performed alongside serial dilutions of a known amount of barcoded cDNA 
previously amplified. Sample Cq’s were referenced to Cq’s of the serial dilutions to determine 
approximate concentrations of barcoded transcripts per total RNA loaded per replicate. Of the 30 
µL volume of cDNA remaining in each replicate, total barcoded molecules were estimated. 30 
µL of the replicate with the lower concentration of barcoded molecules was used in the following 
PCR while a portion of the replicate with the higher concentration was used to approximate 
similar cDNA input into the following PCR. Both amounts loaded covered the original 2.5 x 105 
cell bottleneck amount 24.5-fold. 
 cDNA was amplified with NEBNext Q5 Hot Start HiFi PCR Master Mix (New England 
Biolabs) using volumes determined from qPCR distributed across 5 replicates each, so as not to 
exceed 10% of the total PCR volume, and with primers specific to luciferase (Creb_Luc_Seq_R) 
and a 20 nt annealing site added during reverse-transcription (Creb_Hand). PCR conditions were 
followed as recommended with 61°C annealing for 20s, extension at 72°C for 20s and a final 
extension at 72°C for 2 minutes for a total of 16 cycles. A second PCR was performed in order to 
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add P5 and P7 illumina flow cell adapter sequences and indices. NEBNext Q5 Hot Start HiFi 
PCR Master Mix (New England Biolabs) was used with 0.5 ng cDNA and the primers 
P5_Seq_Luc_F and P7_Ind_##_Han, with ## corresponding to the index code per sample 
indicated in Table 2.1. PCR conditions were followed as recommended with 63°C annealing for 
20s, extension at 72°C for 25s and a final extension at 72°C for 2 minutes for a total of 7 cycles. 
 Meanwhile, gDNA was aliquoted into 2 tubes evenly before PCR to establish 2 technical 
replicates per biological replicate. Per technical replicate, gDNA was amplified with NEBNext 
Q5 Hot Start HiFi PCR Master Mix (New England Biolabs) with a biotinylated reverse-
transcriptase primer Creb_Hand_RT_3 and a biotinylated primer specific to luciferase 
(Creb_Luc_Seq_R). 5 µg gDNA was loaded per 50 µL in a 96-well PCR plate, with 57 total 
reactions per technical replicate for one biological replicate and only 51 for the other, due to 
sample loss. PCR conditions were followed as recommended with 61°C annealing for 20s, 
extension at 72°C for 20s and a final extension at 72°C for 2 minutes. After 7 cycles, wells were 
combined and cleaned-up using Agencourt AMPure XP beads (Beckman Coulter, Brea, CA). 
0.4x volume of beads were used per sample and after magnetic separation, the supernatant was 
collected, isolating the amplicons from genomic DNA. Similar as in (Matreyek et al., 2017), 
40% of eluted volume was used in a second PCR to add P5 and P7 illumina flow cell adapter 
sequences and indices. This volume was distributed across 14 replicates per technical replicate so 
as to not exceed 10% of the total PCR volume and amplified using NEBNext Q5 Hot Start HiFi 
PCR Master Mix (New England Biolabs) with the primers P5_Seq_Luc_F and P7_Ind_##_Han, 
with ## corresponding to the index code per sample. PCR conditions were followed as 
recommended with 63°C annealing for 20s, extension at 72°C for 25s and a final extension at 
72°C for 2 minutes for a total of 14 cycles.  
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 Both the cDNA and gDNA amplicons were isolated on a 2% TAE gel and bands were 
confirmed using Agilent’s D1000 ScreenTape and reagents (Agilent) on a 2200 Tapestation 
system. Samples were mixed equally and sequenced on a HiSeq2500 at UCLA’s Broad Stem 
Cell Research Center using a 1 x 50 kit. Before sequencing, the custom read 1 sequencing primer 
Creb_R1_Seq_P and indexing primer Creb_Ind_Seq_P were loaded into the read 1 and index 
primer positions in the HiSeq cartridge. Indexed samples were de-multiplexed in-house using a 
custom python script that matched indices with those submitted and all 1 bp mutations, 
accounting for sequencing errors. 143,759,096 reads passing filter were obtained across the 2 
biological replicates, each consisting of 2 genomic DNA technical replicates and 1 RNA sample. 
Reads per index ranged between 9 x 106 - 22 x 106. 
 
Processing MPRA Sequencing Data 
 A custom python script was used to isolate barcode sequences from reads and determine 
their total number of reads. Briefly, the first 20 sequences were extracted from each read, reverse 
complemented to match the barcode format from barcode mapping and then the occurence of 
each of these barcodes was summed as their total number of reads per indexed sample. RStudio 
(R version 3.5.3 and the packages: tidyverse 1.2.1, lemon 0.4.3, viridisLite 0.3.0, cowplot 0.9.4, 
caTools 1.17.1.2, broom, 0.5.1, and modelr 0.1.4) was used for the remainder of data processing. 
Barcodes were normalized to sequencing depth per sample and represented as normalized reads 
per million. Barcodes were retained and used in variant expression determination only if they 
also appeared in the barcode-variant mapping table. Barcodes that were present in the barcode-
variant mapping table that were not present in a sample were given the value of 0 normalized 
reads per million amongst retained barcodes. 
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Determining MPRA Variant Expression 
In the episomal MPRA, barcodes were retained across all samples with > 6 reads in the 
DNA sample. Barcode expression was determined by dividing normalized barcode reads per 
million in RNA samples to their normalized reads in the plasmid DNA sample. Variants were 
retained across all samples if they had > 7 barcodes retained in the plasmid DNA sample. 
Median expression per variant was determined by taking the median expression of all barcodes 
associated with a single variant, maintaining variants with > 0 expression in all samples. In total, 
4162 of the original 4185 variants designed along with the CRE control were retained after 
processing. Median variant expression in the single CRE library indicated in Figure 2.8 was 
similarly determined except retaining barcodes across all samples with > 5 reads in the DNA 
sample. 
 In the genomic MPRA, expression was calculated similarly as for the episomal MPRA, 
with changes accounting for 2 DNA technical replicates. Barcodes were retained across all 
samples per biological replicate if they had > 6 reads in both DNA technical replicates. Barcode 
expression was determined by dividing normalized barcode reads per million in RNA samples to 
their average normalized reads across the genomic DNA samples. Per biological replicate, 
variants were similarly retained in the RNA sample if they were associated with > 7 barcodes 
retained in the combined DNA sample. Median expression per variant was determined by taking 
the median expression of all barcodes associated with a single variant. Variants were retained for 
further analysis if they had >0 expression in both biological replicates. Overall, 3479 of the 
original 4185 variants designed were retained in analysis in addition to the CRE control. Variants 
not retained consisted of: 128 from the number and affinity library and 578 from the spacing and 
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distance library (488 of this was with background 41, of which was dropped from analysis). For 
both MPRAs, the average expression between biological replicates was used for all variant 
analyses. 
 
CREB::ßzip structure superpositions along DNA 
 The structure coordinates of a CREB::Bzip dimer bound to the somatostatin CRE 
(Schumacher et al., 2000) was downloaded from PDB (code: 1DH3) and loaded into Coot 
(version 0.8.9.2). Models of CREB protein spacing were made by using the LSQ Superpose 
function, superpositioning a copy of the protein:DNA complex onto the original structure using 
least squares fit to the mainchain of Chain B, corresponding to one DNA strand. Briefly, a model 
of 5 bp CREB protein spacing was established by taking residues -10:-4 on Chain B of the 
reference structure and moving them to residues 4:10 on Chain B. This matched 63 atoms with a 
rms deviation of 1.22. A model of 10 bp CREB protein spacing was established by taking 
residues -11:-9 on Chain B of the reference structure and moving them to residues 8:10 on Chain 
B. This matched 26 atoms with an rms deviation of 1.49. 
 A model of six CREB proteins bound to six CREs in the Number and Affinity library was 
constructed similarly. CREB protein bound to the first CRE was created by taking residues 5:9 
on Chain B of the reference structure and moving them to residues -9:5 on Chain B. CREB 
protein bound to the second CRE was created by taking residues -9:5 on Chain B of the reference 
structure and moving them to residues 4:8 on Chain B. The third instance of CREB protein-CRE 
was created by taking residues -9:-5 on Chain B of the reference structure of the second CREB 
protein-CRE and moving them to residues 5:9 on Chain B then taking residues -9:5 on Chain B 
of this new reference structure and moving them to residues 4:8 on Chain B. This was repeated 
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sequentially using the previous CREB protein-CRE structure as a reference until 
superpositioning the sixth instance of CREB protein bound to a CRE. A total of 10 LSQ 
superpositions were performed matching 45 atoms each time with a rms deviation of either 1.15 
or 1.09 depending upon the reference and moving residues. 
 
Log-linear expression modelling 
 A model was fit using lm()in R stats package to predict average expression from the 
independent contribution of background and the 6 CRE positions in the site number and affinity 
library (expression ~ background + site1 + site2 + site3 + site4 + site5 + site6). Background and 
each position was represented as categorical variables according to the 3 backgrounds used and 3 
possible affinities per position (consensus CRE, weak CRE, and no CRE). The percent of 
variance explained per model term was obtained using the sum of squares from anova(). 
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Figure 2.6. Establishment of the episomal and genomic MPRA. (A) Library-containing vectors are 
genomically-integrated by co-transfecting with a BxB1 expression vector into a HEK293T cell line containing a 
single-copy landing pad at the H11 locus. BxB1-mediated integration occurs through the genomic recombination 
site, attP, and the vector recombination site, attB. Successful integration at H11 switches cell antibiotic 
resistance from hygromycin to puromycin, via the genomic CAGGS promoter, in addition to driving expression 
of eGFP. Vector and landing pad components not shown to scale. (B) Integration of library-containing vectors in 
the genomic MPRA was monitored using eGFP activation upon genomic integration. 5.11% of transfected cells 
expressed eGFP from an integrated construct (cyan). Successful integrants were isolated after outgrowth in 
media containing puromycin (green). (C) Integration orientation of library controls at the landing pad resulted in 
different levels of induced expression. The negative strand orientation placed the attL sequence immediately 
upstream of the CRE control while in the positive strand orientation, this was replaced by bacterial 
backbone.The negative strand orientation was chosen for the genomic CRE MPRA. Lines indicate a loess fit 
with shaded regions indicated standard error. (D, top graph) Bulk genomically-integrated library luciferase 
expression measured across forskolin dilutions, 6 technical replicates each. The genomic MPRA was performed 
using 8 µM forskolin for comparisons to the episomal MPRA. (D, bottom graph) Similar bulk luciferase 
expression measurements but after transfection of the episomal library. Luciferase luminescence normalized to 
luminescence from a Renilla transfection control. The episomal MPRA analysis was performed at 4 µM 
forskolin for comparisons to the genomic MPRA. In both graphs, lines indicate a loess fit with shaded regions 
indicated standard error. (E) Replicability plots following the episomal MPRA titration curve in figure 2.1 D. 
Expression from each variant was normalized to the expression of their corresponding background per biological 
replicate to visualize induction following increasing forskolin. Replicability ranged from r = 0.96 to r = 0.99 
across concentrations. 
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Figure 2.7 Episomal MPRA tested at 
concentrations beyond maximal induction indicate 
little change in expression range. (A) The episomal 
MPRA was performed at concentrations spanning 
beyond those used in the main analysis (Figure 2.1 D 
and Figure 2.6 E) to confirm the full induction range 
in episomal conditions. (B) Repeated concentrations 
between episomal MPRAs indicate high 
reproducibility (r = 0.94-0.99). 
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Figure 2.8 Variants with one CRE drive 
minimally-induced expression and do not 
indicate large expression variation as CRE 
distance to the promoter is varied in the 
episomal MPRA. Variants containing a 
single CRE at every position along the three 
backgrounds assayed in an separate MPRA at 
uninduced and fully-induced forskolin 
concentrations. Variant expression is 
normalized to the expression of their 
backgrounds, averaged across replicates and 
compared between forskolin concentrations. 
Line shown is the 3 bp moving average 
expression estimate. As the distance of one 
CRE to the promoter varies there is little 
expression variation in all but a portion of 
distances in variants with background 52. 
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Figure 2.9. Expression measurements for all variants in the CRE Spacing and Distance library retained in 
analysis. All MPRA expression measurements used for analysis of variants in the Spacing and Distance library. 
Comparisons to the episomal MPRA were performed with expression obtained at 4 µM forskolin. Data quality 
filters in the genomic MPRA remove 74% of variants with background 41, thus only episomal MPRA expression 
is used for periodicity analysis in variants with this background in Figure 3. Similar normalized expression 
profiles are observed between variants in the episomal and genomic context. Variants with 0 bp CRE spacing 
were predicted to occlude the binding of CREB protein to both CREs; here we observe minimal expression 
driven by these variants. 
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Figure 2.10 Variant periodicity offset graphs as in Fig. 3A with backgrounds 55 and 52 in both MPRAs. 
Average variant expression across replicates according to proximal CRE distance to the promoter (x-axis) is 
subset according to background and MPRA and colored by the spacing between CREs. The line corresponds to a 
3 bp moving average estimate. Variants with background 55 in the episomal MPRA display a similar offset 
between 5 and 10 bp spacings and alignment between both 5 and 15 bp and 10 and 20 bp spacings. Dashed lines 
correspond points at local expression maxima across CRE distances or the midpoint between points if a maxima 
was not apparent in variants with 5 and 10 bp CRE spacings. Similar periodicity offsets and alignments are not 
as pronounced along this background in the genomic MPRA and along background 52 in both MPRAs. 
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Figure 2.11 Expression measurements for all variants in the follow-up CRE Spacing and Distance 
library retained in analysis. Average normalized variant expression across replicates in an episomal 
MPRA is indicated according to distal CRE distance to the minimal promoter. Variants are subset by 
background and spacing between CREs. The line corresponds to a 3 bp moving average estimate while 
dashed red lines correspond to clear points of local expression maxima, determined as averages across 
CRE spacings. While ~10 bp periodicity is not constant across all distances along backgrounds 
(background 52), when present, expression periodicity follows similar phasing across spacings when 
plotted according to the distal CRE distance to the minimal promoter. 
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Figure 2.12 CREs in the Number and Affinity library were placed at positions which were expected to 
sample multiple CREB protein orientations along DNA. Using the published structure of a CREB::bZIP 
dimer bound to CRE (PDB: 1DH3), we modeled the expected placement of CREB dimers bound to the 6 CRE 
sites and constant 17 bp CRE spacing used in the CRE Number and Affinity library. Orientation of each CREB 
dimer is indicated relative to the first dimer following CRE distances relative to the minimal promoter. 
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Figure 2.13 The number of consensus CREs in 
variants largely determines expression while the 
number of weak CREs has a variable effect 
between episomal and genomic MPRAs. Similar as 
in Fig. 4A, variants with background 41 and 52 in both 
MPRAs grouped according to their total number of 
both consensus (x-axis) and weak CREs (colored 
subsets) and average expression plotted per variant per 
MPRA (y-axis). The number of consensus CREs 
largely determines the expression per variant and 
drives a non-linear trend in expression. For reasons 
that are not apparent, the number of weak CREs per 
variant drives a similarly non-linear increase in 
expression across all variants but those with 
background 41 in the episomal MPRA.  
Figure 2.14 Library member expression largely correlates between 
MPRA formats. Despite differences, library variant expression correlates 
well between the episomal and genomic MPRA (r = 0.91).  
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Subpool_2_F GCTCTCCGCTATCAGTAACA 
Subpool_3_F CCGATAGGAGGGGAGAGTTA 
Subpool_5_F ATTACCATGTTATCGGGCGA 
Subpool_2_R CCAAATAGGATGTGTGCTCG 
Subpool_3_R CTGGTATAGTCTCCTCAGCG 
Subpool_5_R ATCTAAACCACGACCTCAGG 
SP2_Biotin /5Biosg/GCTCTCCGCTATCAGTAACA 
SP3_Biotin /5Biosg/CCGATAGGAGGGGAGAGTTA 
SP5_Biotin /5Biosg/ATTACCATGTTATCGGGCGA 
SP2_Biotin_BC_R /5Biosg/AAGTCGACTAGTNNNNNNNNNNNNNNNNNN
NBTCTAGACCAAATAGGATGTGTGCTCG 
SP3_Biotin_BC_R /5Biosg/AAGTCGACTAGTNNNNNNNNNNNNNNNNNN
NBTCTAGACTGGTATAGTCTCCTCAGCG 
SP5_Biotin_BC_R /5Biosg/AAGTCGACTAGTNNNNNNNNNNNNNNNNNN
NBTCTAGAATCTAAACCACGACCTCAGG 
Table 2.1. List of primers and sequences used throughout this study. 
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Amp_minPLuc2_Biotin_Rev /5Biosg/CACAGGAAACAGCTATGACC 
Amp_minPLuc2_Biotin_For /5Biosg/ACGACGTTGTAAAACGACGG 
LibSeq_P5_Rev AATGATACGGCGACCACCGAGATCTACACGTAACCA
CCCTGATCGACGG 
LibSeq_P7_For CAAGCAGAAGACGGCATACGAGATTCGGCAGTTGGG
AAGAGCATAGTCG 
LibSeq_R1Seq_Rev GTAACCACCCTGATCGACGGGGAGTGTACTAGT 
LibSeq_R2Seq_For TCGGCAGTTGGGAAGAGCATAGTCGTAGAGCACGCG
T 
Creb_Hand_RT ATGCTCTTCCCAACTGCCGACGACGGGGAGTGTACT
AGT 
Creb_Hand ATGCTCTTCCCAACTGCCGA 
Creb_Seq_Luc_R TACAACCGCCAAGAAGCTGC 
P5_Seq_Luc_F AATGATACGGCGACCACCGAGATCTACACTACAACC
GCCAAGAAGCTGC 
P7_Ind_11_Han CAAGCAGAAGACGGCATACGAGATCGAGGCTGGCG
TGCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_5_Han CAAGCAGAAGACGGCATACGAGATACCCAGCAGCG
TGCTCTACGACTATGCTCTTCCCAACTGCCGA 
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P7_Ind_2_Han CAAGCAGAAGACGGCATACGAGATGTGTGGTGGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_3_Han CAAGCAGAAGACGGCATACGAGATTGGGTTTCGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_4_Han CAAGCAGAAGACGGCATACGAGATCATGCCTAGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_D3_Han CAAGCAGAAGACGGCATACGAGATAACCCCTCGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_R0A_Han CAAGCAGAAGACGGCATACGAGATATCACGACGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_R0B_Han CAAGCAGAAGACGGCATACGAGATTAAGGCGAGCG
TGCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_R1A_Han CAAGCAGAAGACGGCATACGAGATAAGAGGCAGCG
TGCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_R1B_Han CAAGCAGAAGACGGCATACGAGATGCTACGCTGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_R2A_Han CAAGCAGAAGACGGCATACGAGATCAGAGAGGGCG
TGCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_R2B_Han CAAGCAGAAGACGGCATACGAGATAGGAGTGGGCG
 69 
TGCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_R4A_Han CAAGCAGAAGACGGCATACGAGATCAGATCCAGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_R4B_Han CAAGCAGAAGACGGCATACGAGATGGACTCCTGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_R8A_Han CAAGCAGAAGACGGCATACGAGATTCGCCTTAGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_Ind_R8B_Han CAAGCAGAAGACGGCATACGAGATACAAACGGGCG
TGCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_In_R16A_Han CAAGCAGAAGACGGCATACGAGATAGGCAGAAGCG
TGCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_In_R16B_Han CAAGCAGAAGACGGCATACGAGATCGTACTAGGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_In_R25A_Han CAAGCAGAAGACGGCATACGAGATCTCTCTACGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_In_R25B_Han CAAGCAGAAGACGGCATACGAGATAGGGTCAAGCG
TGCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_In_R32A_Han CAAGCAGAAGACGGCATACGAGATGTAGAGGAGCG
TGCTCTACGACTATGCTCTTCCCAACTGCCGA 
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P7_In_R32B_Han CAAGCAGAAGACGGCATACGAGATTGTGACCAGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_In_R64A_Han CAAGCAGAAGACGGCATACGAGATACAGTGGTGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
P7_In_R64B_Han CAAGCAGAAGACGGCATACGAGATCCCAACCTGCGT
GCTCTACGACTATGCTCTTCCCAACTGCCGA 
Creb_Ind_Seq_P TCGGCAGTTGGGAAGAGCATAGTCGTAGAGCACGC 
Creb_R1_Seq_P CCAAGAAGGGCGGCAAGATCGCCGTGTAATAATTCT
AGA 
Creb_RT_Hand_3 ATGCTCTTCCCAACTGCCGAAACCACCCTGATCGAC
GGGG 
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Comparison between episomal and single-copy, genomic MPRA formats 
 We present the first systematic comparison between the more typical, episomal MPRA 
format and a single-copy, genomically-integrated MPRA in mammalian cells exploring 
sequence-function relationships of TFBS architecture. Genomic MPRAs are becoming more 
popular due to their expected approximation of genomic transcription by being placed in a more 
natural, chromatin context (Inoue et al., 2017; Klein et al., 2019; Weingarten-Gabbay et al., 
2019, Maricque et al., 2018). Yet these assays require more time, resources, experimental steps, 
and in certain cases special cell lines, as used here. Additionally, they place restrictions on the 
number of constructs feasibly tested and can suffer from loss of library coverage as observed in 
this study. Therefore, single-copy genomic MPRAs limit the high-throughput nature of the 
MPRA itself. Nevertheless, these limitations may be accommodated if episomal assays indeed 
fail to characterize genomic trends in expression.  
Here we compare MPRA formats between library members varying cis-regulatory 
architecture of a model TFBS and find a number of differences. 1) Although variations in CRE 
distance drive similar expression periodicities between MPRA formats, the amplitude of this 
effect is heightened in the genomic MPRA. 2) In addition to this, the role of spacing on 
expression periodicity varied between MPRA formats. Although variants containing the 
background with the clearest change in expression periodicity in the episomal MPRA were 
dropped from the genomic MPRA analysis due to sequencing coverage, comparisons between 
the other backgrounds did not indicate similar changes in periodicity phasing from CRE spacings 
in the genomic MPRA. This may imply the precise positioning of CREs upstream of a promoter 
may have different effects on expression in a genomic context. In line with the finding that 
CREB protein orientation near nucleosomes modulates CRE binding occupancy (Zhu et al., 
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2018), further MPRA characterizations of nucleosomal deposition along variants with varied 
CRE spacings and distances, similar to (Levo et al., 2017), may explain this disconnect. 3) 
Lastly, as indicated in Chapter 2, the role of CRE affinity in driving expression differed greatly 
between assay formats. Yet this may have been an artifact of testing sequences containing 
variations of the same TFBS. Thus TFBS affinity may not play as large of a role in episomal 
MPRAs performed on library members with diverse TFBSs.  
Overall, the comparison between single-copy, genomic and episomal MPRAs implies 
episomal assays can approximate overall trends but may miss out on some of the finer details 
obtained in genomic assays. While lentiviral assays present their own issues, increasing copy 
numbers of genomic assays even slightly using other means may simplify experimental methods. 
Using established and well-characterized cell lines with multiple landing pads, similar to the 
single-copy version here, would simplify genomic MPRAs by decreasing the cells and 
RNA/DNA required for processing while still avoiding TF competition with 101-104 copy 
numbers in transfected MPRAs. While library member expression can differ across landing pads 
due to local chromatin effects (Maricque et al., 2018), cell lines can be generated containing 
landing pads in loci with similar effects on constructs. 
 
Current understandings of sequence-function relationships governing CRE-directed gene 
expression 
 By manipulating regulatory architecture in a more controlled manner rather than relying 
on genomic sequences, we have isolated the effects of a number of variables influencing 
expression from CREs. First and foremost, CRE number and affinity are the largest determinants 
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of expression, as would be expected. Similar to other findings (Gertz et al., 2009; Sharon et al., 
2012; Weingarten-Gabbay et al., 2019), CRE number followed a non-linear trend in expression, 
with combined CRE affinity along variants scattered throughout the overall trend. We anticipate 
within this trend, which is shaped by active TF levels (van Dijk et al., 2017), CRE distance, 
spacing, and the surrounding sequence content further modulates expression. The overall 
distance between CRE and the minimal promoter tested here largely influenced CRE activity, 
both observed in the placement of multiple CREs along variants and when iteratively tested in 
the CRE Spacing and Distance library. Yet, assay designs constricted the distances tested to 
within 67 bp of the minimal promoter, curtailing the full characterization of CRE distance 
effects. Further characterizations minimizing this distance may reveal greater increases in CRE 
activity and may also provide more insight on CRE’s expression periodicity and spacing effects, 
especially on the role of the distal CRE in driving periodicity phasing. Additionally, CRE 
spacing may have played a role in the trends observed from the CRE Number and Affinity 
library expression. More sequences manipulating CRE spacings and distances in cis-regulatory 
elements with greater than 2 CREs is needed to explore the full impact non-optimal spacing has 
on overall expression in these cases. Lastly, the role of surrounding sequence content was not 
fully explored here as only 3 backgrounds were tested, but further work across more 
backgrounds may reveal an overall trend or motif co-occurrence following CRE activity. In 
conjunction with more sequences, it is likely necessary to assay combinations of features tested 
here to fully capture the variation in expression from CREs in cis-regulatory elements. For 
instance, increasing GC content between binding sites for other proteins has ameliorated the ~10 
bp binding periodicity observed from varied site spacings (Kim et al., 2013). Construction of a 
more predictive model, following additional characterizations of larger libraries of CRE 
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manipulations in addition to molecular modeling, may accurately capture all these features and 
likely would rely on a combination of the overall CRE distance to promoter motifs, CRE 
distance within ~10 bp intervals, local sequence content and its interaction with CRE spacing 
and distance effects, and overall CRE number and affinity. 
 
Extrapolation of findings to other TFBSs 
 I expect many of the features assayed here to also play a role in expression from cis-
regulatory elements with non-CRE TFBSs. Overall TFBS number and affinities will likely also 
fill out an overall non-linear trend in expression, although the combination of active TF levels 
per cell state would influence the magnitude of this trend. Of course, the combinatorial logic of 
TF pairs and their conserved TFBS arrangements will guide the effects of specific TFBS 
combinations. This was not assayed here and presents an added layer of difficulty in predicting 
cis-regulatory element activity from sequence alone. Some TFs do not activate on their own and 
require obligatory partners in driving transcription (Stampfel et al., 2015), yet confirming which 
combinations of TFs drives expression presents itself as its own heroic endeavor alone. Although 
obligatory TFBS spacings and orientations have been mapped for many combinations of TFs in 
vitro (Jolma et al., 2013, 2015), these relationships are further complicated by local sequence 
content and overall distances to non-interacting TFs or members of the pre-initiation complex 
within cis-regulatory elements. Additionally, expanding the trends observed here to other TFBSs 
that localize around TSSs may reveal similar or different distance-dependencies, perhaps based 
on specific interactions to general transcription factors and coactivators. In the end, I believe the 
strength of sequence-based prediction models will lie in approximating expression from cis-
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regulatory elements, with precise estimations only for those with TFBSs that have been well-
characterized. This precision will be guided by measurements of active TF levels per cell type 
and state, obligatory TFBS spacings and partners, TF-induced local changes to the DNA (as 
mentioned with potential spacing effects in Chapter Two), overall distance-dependence to 
promoter elements, specific distance effects following TF helical phasing, and lastly local 
sequence content. I anticipate a combination of biophysical-based models along with high-
throughput sequence characterizations similar to that which is presented here will aid such 
predictions of sequence-function relationship driving gene expression.  
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